Filing Details

Accession Number:
0000950170-25-075470
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-20 19:13:03
Reporting Period:
2025-05-16
Filing Date:
2025-05-20
Accepted Time:
2025-05-20 19:13:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224091 L David Mahoney C/O Corcept Therapeutics Incorporated
101 Redwood Shores Parkway
Redwood City CA 94065
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-16 30,000 $6.55 30,000 No 4 M Direct
Common Stock Disposition 2025-05-16 2,648 $74.21 27,352 No 4 F Direct
Common Stock Disposition 2025-05-16 23,829 $74.17 3,523 No 4 S Direct
Common Stock Disposition 2025-05-16 3,523 $74.65 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2025-05-16 30,000 $0.00 30,000 $6.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-06-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,212,614 Indirect Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
Common Stock 46,147 Indirect The Black Dog Private Foundation
Footnotes
  1. These shares were withheld so the Reporting Person could satisfy the exercise price liability arising from a net (cashless) exercise of stock options that occurred on May 16, 2025. The options subject to the net exercise were to expire on June 18, 2025.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.54 to $74.525 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  3. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.54 to $74.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  4. Fully exercisable.